223 related articles for article (PubMed ID: 35565465)
1. Impact of Secretion-Active Osteoblast-Specific Factor 2 in Promoting Progression and Metastasis of Head and Neck Cancer.
Gül D; Schweitzer A; Khamis A; Knauer SK; Ding GB; Freudelsperger L; Karampinis I; Strieth S; Hagemann J; Stauber RH
Cancers (Basel); 2022 May; 14(9):. PubMed ID: 35565465
[TBL] [Abstract][Full Text] [Related]
2. Bone marrow mesenchymal stem cells promote head and neck cancer progression through Periostin-mediated phosphoinositide 3-kinase/Akt/mammalian target of rapamycin.
Liu C; Feng X; Wang B; Wang X; Wang C; Yu M; Cao G; Wang H
Cancer Sci; 2018 Mar; 109(3):688-698. PubMed ID: 29284199
[TBL] [Abstract][Full Text] [Related]
3. Prognostic signature associated with radioresistance in head and neck cancer via transcriptomic and bioinformatic analyses.
You GR; Cheng AJ; Lee LY; Huang YC; Liu H; Chen YJ; Chang JT
BMC Cancer; 2019 Jan; 19(1):64. PubMed ID: 30642292
[TBL] [Abstract][Full Text] [Related]
4. Nuclear Localization of DNAJB6 Is Associated With Survival of Patients With Esophageal Cancer and Reduces AKT Signaling and Proliferation of Cancer Cells.
Yu VZ; Wong VC; Dai W; Ko JM; Lam AK; Chan KW; Samant RS; Lung HL; Shuen WH; Law S; Chan YP; Lee NP; Tong DK; Law TT; Lee VH; Lung ML
Gastroenterology; 2015 Dec; 149(7):1825-1836.e5. PubMed ID: 26302489
[TBL] [Abstract][Full Text] [Related]
5. Expression of Osteoblast-Specific Factor 2 (OSF-2, Periostin) Is Associated with Drug Resistance in Ovarian Cancer Cell Lines.
Sterzyńska K; Kaźmierczak D; Klejewski A; Świerczewska M; Wojtowicz K; Nowacka M; Brązert J; Nowicki M; Januchowski R
Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31412536
[TBL] [Abstract][Full Text] [Related]
6. TEAD4 functions as a prognostic biomarker and triggers EMT via PI3K/AKT pathway in bladder cancer.
Chi M; Liu J; Mei C; Shi Y; Liu N; Jiang X; Liu C; Xue N; Hong H; Xie J; Sun X; Yin B; Meng X; Wang B
J Exp Clin Cancer Res; 2022 May; 41(1):175. PubMed ID: 35581606
[TBL] [Abstract][Full Text] [Related]
7. Significance of lymph node metastasis in cancer dissemination of head and neck cancer.
Cho JK; Hyun SH; Choi N; Kim MJ; Padera TP; Choi JY; Jeong HS
Transl Oncol; 2015 Apr; 8(2):119-25. PubMed ID: 25926078
[TBL] [Abstract][Full Text] [Related]
8. Identification of cytokeratin24 as a tumor suppressor for the management of head and neck cancer.
Gül D; Habtemichael N; Dietrich D; Dietrich J; Gößwein D; Khamis A; Deuss E; Künzel J; Schneider G; Strieth S; Stauber RH
Biol Chem; 2022 Jul; 403(8-9):869-890. PubMed ID: 34450690
[TBL] [Abstract][Full Text] [Related]
9. Exosome-derived long non-coding RNA ADAMTS9-AS2 suppresses progression of oral submucous fibrosis via AKT signalling pathway.
Zhou S; Zhu Y; Li Z; Zhu Y; He Z; Zhang C
J Cell Mol Med; 2021 Feb; 25(4):2262-2273. PubMed ID: 33345447
[TBL] [Abstract][Full Text] [Related]
10. The circEPSTI1/mir-942-5p/LTBP2 axis regulates the progression of OSCC in the background of OSF via EMT and the PI3K/Akt/mTOR pathway.
Wang J; Jiang C; Li N; Wang F; Xu Y; Shen Z; Yang L; Li Z; He C
Cell Death Dis; 2020 Aug; 11(8):682. PubMed ID: 32826876
[TBL] [Abstract][Full Text] [Related]
11. The membrane mucin MUC4 is elevated in breast tumor lymph node metastases relative to matched primary tumors and confers aggressive properties to breast cancer cells.
Workman HC; Miller JK; Ingalla EQ; Kaur RP; Yamamoto DI; Beckett LA; Young LJ; Cardiff RD; Borowsky AD; Carraway KL; Sweeney C; Carraway KL
Breast Cancer Res; 2009; 11(5):R70. PubMed ID: 19761616
[TBL] [Abstract][Full Text] [Related]
12. CXCR3 isoform A promotes head and neck cancer progression by enhancing stem-like property and chemoresistance.
Sun WH; Peng TJ; Tang SJ; Lin JY; Wang CY; Fang HJ; Sun KH
J Oral Pathol Med; 2022 Oct; 51(9):791-800. PubMed ID: 35998229
[TBL] [Abstract][Full Text] [Related]
13. Nrf2 inhibition reverses the resistance of cisplatin-resistant head and neck cancer cells to artesunate-induced ferroptosis.
Roh JL; Kim EH; Jang H; Shin D
Redox Biol; 2017 Apr; 11():254-262. PubMed ID: 28012440
[TBL] [Abstract][Full Text] [Related]
14. Advances in Head and Neck Cancer Pain.
Ye Y; Jensen DD; Viet CT; Pan HL; Campana WM; Amit M; Boada MD
J Dent Res; 2022 Aug; 101(9):1025-1033. PubMed ID: 35416080
[TBL] [Abstract][Full Text] [Related]
15. RhoC GTPase expression as a potential marker of lymph node metastasis in squamous cell carcinomas of the head and neck.
Kleer CG; Teknos TN; Islam M; Marcus B; Lee JS; Pan Q; Merajver SD
Clin Cancer Res; 2006 Aug; 12(15):4485-90. PubMed ID: 16899593
[TBL] [Abstract][Full Text] [Related]
16. IGF2 Mediates Resistance to Isoform-Selective-Inhibitors of the PI3K in HPV Positive Head and Neck Cancer.
Badarni M; Prasad M; Golden A; Bhattacharya B; Levin L; Yegodayev KM; Dimitstein O; Joshua BZ; Cohen L; Khrameeva E; Kong D; Porgador A; Braiman A; Grandis JR; Rotblat B; Elkabets M
Cancers (Basel); 2021 May; 13(9):. PubMed ID: 34067117
[TBL] [Abstract][Full Text] [Related]
17. HPV-mediated regulation of SMAD4 modulates the DNA damage response in head and neck cancer.
Citro S; Miccolo C; Medda A; Ghiani L; Tagliabue M; Ansarin M; Chiocca S
J Exp Clin Cancer Res; 2022 Feb; 41(1):59. PubMed ID: 35144669
[TBL] [Abstract][Full Text] [Related]
18. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
19. Suppression of Aurora-A-FLJ10540 signaling axis prohibits the malignant state of head and neck cancer.
Chen CH; Chang AY; Li SH; Tsai HT; Shiu LY; Su LJ; Wang WL; Chiu TJ; Luo SD; Huang TL; Chien CY
Mol Cancer; 2015 Apr; 14():83. PubMed ID: 25889801
[TBL] [Abstract][Full Text] [Related]
20. Low-dose arecoline regulates distinct core signaling pathways in oral submucous fibrosis and oral squamous cell carcinoma.
Li Z; Fu Y; Hu Y; Zhu Y; Hu L; Shi C; Zhang Y; Zhang J; Zhou S
BMC Oral Health; 2023 Mar; 23(1):171. PubMed ID: 36966276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
